About us

We’re Leukaemia UK. We believe research has the power to stop leukaemia devastating lives.   

Person stood on a graphited wall, smiling at the camera

Despite decades of incredible progress, only half of leukaemia patients live longer than five years after their diagnosis. We won’t stop until we change this.  

Bringing together the leukaemia community, we will accelerate progress through life-changing research, doing everything we can to make sure that the next person with leukaemia has the best possible experience of diagnosis, treatment and care. 

We will bolster the science by raising greater awareness of the disease to improve survival and championing the voice of leukaemia patients so we can make sure they have access to the best available therapies and care.  

Photo credit (top): Jeff Moore

Discoveries happen all the time

Leukaemia UK’s bold website and brand embodies our desire to be a greater force for change and brings our strategy to life.

Please note, statistics in video above were correct at time of publishing (2022). 

Our impact

Our impact

Our strategy

Our strategy

Who we work with
People sat around a table talking

Who we work with

Vacancies

Vacancies

Governance
3 people sat around a desk in the Leukaemia UK offices laughing

Our Governance

Board of Trustees

Our Board of Trustees

Latest news

“Leukaemia has changed my life for ever”

7 July 2026 Patient

“Leukaemia has changed my life for ever”

A devastating relapse nine months after her stem cell transplant launched Ruth Wake into a “fight for her life” which would eventually instigate a national campaign for change. Ruth was…

“Leukaemia has changed my life for ever”

2 July 2026 Patient

“Leukaemia has changed my life for ever”

In the summer of 2015, 28-year-old Billie McPartlan was building her career as a PA working at Canary Wharf in London. She had enjoyed a holiday to Ibiza with friends and was excitedly planning her wedding to Tony the…

A Second Chance at Life

19 June 2026 Patient

A Second Chance at Life

For patients with blood cancer such as leukaemia, a stem cell transplant can offer the chance of a cure. But when a transplant fails or the disease returns, some patients may need a second transplant to have hope of long-term survival. Despite advances in transplant medicine, an NHS England policy introduced in 2017 continues to restrict access to second stem cell transplants based on a rigid ’12-month rule’.
In this blog series, we explore why the policy is under review, how treatment outcomes have changed over the last decade, and why charities including Leukaemia UK, Anthony Nolan and DKMS are calling for a more personalised, evidence-based approach to care.